Stockscreener 앱 받기
2.21
0.45%
-0.01
시간 외 거래:
2.21
전일 마감가:
$2.22
열려 있는:
$2.22
하루 거래량:
225.91K
Relative Volume:
0.32
시가총액:
$140.13M
수익:
$4.39M
순이익/손실:
$-22.40M
주가수익비율:
-4.335
EPS:
-0.5098
순현금흐름:
$-22.79M
1주 성능:
-7.53%
1개월 성능:
-2.21%
6개월 성능:
+26.29%
1년 성능:
+26.29%
1일 변동 폭
$2.20
$2.25
1주일 범위
$2.18
$2.39
52주 변동 폭
$0.7562
$3.54
Equillium Inc Stock (EQ) Company Profile
명칭
Equillium Inc
전화
(858) 412-5302
주소
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Compare EQ vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EQ
Equillium Inc
|
2.21 | 143.94M | 4.39M | -22.40M | -22.79M | -0.5098 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-23 | 개시 | Oppenheimer | Outperform |
| 2026-04-16 | 개시 | B. Riley Securities | Buy |
| 2026-04-14 | 개시 | Raymond James | Strong Buy |
| 2026-04-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2026-03-13 | 개시 | Roth Capital | Buy |
| 2026-02-25 | 개시 | Stifel | Buy |
| 2025-03-28 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2021-10-29 | 재개 | Stifel | Buy |
| 2021-09-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-07-14 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-10 | 재개 | Stifel | Buy |
| 2019-02-22 | 개시 | SVB Leerink | Outperform |
모두보기
Equillium Inc 주식(EQ)의 최신 뉴스
Equillium Stock Price Forecast. Should You Buy EQ? - StockInvest.us
EQ Reiterates by Roth Capital -- Price Target Maintained at $12 - GuruFocus
Equillium to Participate in Upcoming Investor Conferences - Yahoo Finance
EQ | Equillium, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Equillium Inc (NASDAQ: EQ) Share Price, EQ Stock News, EQ Share Price & Updates - Kalkine
Equillium (EQ) Q1 2026 Earnings: The EPS Result Is Below Expectation in the Available Record; Closing Reaction: Shares Finish 0.85% Lower at the CloseEarnings Acceleration Picks - vinanet.vn
Equillium (EQ) Earnings Report: EPS Misses Its Estimate in the Latest Session; Trading Response - vinanet.vn
3 Promising Penny Stocks With Market Caps Under $400M - simplywall.st
Equillium (NASDAQ:EQ) Rating Increased to Hold at Wall Street Zen - MarketBeat
Oppenheimer Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $7 - Moomoo
EQ Q1 2026 Earnings: EPS Miss of 34.5% Drives 7.8% Stock DeclineDividend Increase Stocks - vinanet.vn
Roth MKM Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Equillium (NASDAQ:EQ) Announces Earnings Results - MarketBeat
Equillium Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Form 8K Equillium Inc For: 13 August By Investing.com - Investing.com Nigeria
Equillium Inc. (EQ) Drops 7.8% to $2.01 as Support at $1.91 Comes Into FocusKAMA Signal - vinanet.vn
Equillium, Inc. Q2 2026: Net loss $(4.7)M, EPS $(0.04) — 10-Q Summary - TradingView
Equillium Q2 post narrower net loss than expected; starts R&D initiatives - TradingView
Equillium, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Affinity Asset Advisors reports 4.1M Equillium (EQ) shares, a 6.5% stake - Stock Titan
Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - The Manila Times
EQ Q1 2026 Earnings: EPS Misses Estimates with Wider-than-Expected Loss of -$0.06Fiscal Year Earnings - vinanet.vn
Equillium (NASDAQ:EQ) Upgraded by Zacks Research to "Hold" Rating - MarketBeat
Adage Capital discloses 7.25% Equillium (EQ) stake via Schedule 13G/A filing - Stock Titan
EQ Q1 2026 Earnings: Wider-than-Expected Loss Leaves Shares LowerAnnual Financial Report - vinanet.vn
EQ Q2'26 Earnings: EPS estimate is (0.05) USD - TradingView
Equillium Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
Equillium, Inc. (NASDAQ:EQ) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Equillium Inc (EQ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Equillium (EQ) Holds Near $2.11 as Stock Tests $2.0 SupportWyckoff Distribution - vinanet.vn
Equillium (EQ) Projected to Announce Earnings on Thursday - MarketBeat
EQ Q2'26 Earnings: revenue estimate is 0 USD - TradingView
Equillium, Inc. $EQ Holdings Lifted by Janus Henderson Group PLC - MarketBeat
Clear Street Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $9 - Moomoo
EQ Q1 2026 Earnings: Wider-than-Expected Loss Sends Shares Down 5.17%EPS Revision Trend - vinanet.vn
Equillium Inc. (EQ) Shows Modest Gain as Shares Test Key ResistanceHigh Volume Node - dars.gov.et
ADAR1 Capital Management LLC Has $7.45 Million Position in Equillium, Inc. $EQ - MarketBeat
1,498,993 Shares in Equillium, Inc. $EQ Purchased by Eversept Partners LP - MarketBeat
EQ|Equillium Inc|Price:2.455|Chg%:-0.035 - TradingKey
Equillium Inc (EQ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Equillium Inc (EQ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Equillium Inc (EQ) Cash Flow - TradingKey
Equillium Inc (EQ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
EQ|Equillium Inc|Price:2.490|Chg%:-0.200 - TradingKey
Equillium Inc (EQ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
EQ|Equillium Inc|Price:2.580|Chg%:+0.090 - TradingKey
Equillium Inc (EQ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TradingKey - TradingKey
Equillium Inc (EQ) Balance Sheet - TradingKey
1,226,310 Shares in Equillium, Inc. $EQ Acquired by Affinity Asset Advisors LLC - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Equillium (EQ), CSL (CMXHF) - The Globe and Mail
Equillium Inc (EQ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.31%
자본화:
|
볼륨(24시간):